GNUBIOTICS

Glyopeptide variants developed by Gnubiotics have been demonstrated to reduce the onset of diet induced obesity and enhance thermogenesis through a number of hypothesized mechanisms of action. Gnubiotics is interested in further investigating this promising MoAs through partnerships and collaborations... Gnubiotics Sciences SA is partnering with top-tier academic medical centers to move into first clinical trials.

Primary location: Epalinges Switzerland